9th Cachexia Conference Program – Berlin, 10-11 Dec. 2016

Saturday 10th December 2016

Program chairmen

John E. Morley, St. Louis, MO, USA
Stefan D. Anker, Göttingen, Germany


International scientific committee

Stefan D. Anker (President) – Göttingen, Germany
John E. Morley – St. Louis, USA
William J. Evans – Durham, USA
Akio Inui – Kobe, Japan
Josep M. Argiles – Barcelona, Spain
Filippo Rossi-Fanelli – Rome, Italy
Vickie E. Baracos – Edmonton, Canada
Andrew J. S. Coats – Melbourne, Australia and Warwick, UK
Wolfram Doehner – Berlin, Germany
Kenneth C. H. Fearon – Edinburgh, UK
Luigi Ferrucci – Baltimore, USA
David J. Glass – Cambridge, USA
Aminah Jatoi – Rochester, USA
Kamyar Kalantar-Zadeh – Torrance, USA
Florian Strasser – St. Gallen, Switzerland
Stephan von Haehling – Göttingen, Germany


Related links

The society has published a few overview articles
on wasting disorders based on the
Cachexia >
Sarcopenia >
Muscle wasting >


PDF – Berlin 2016 program

Download event program PDF
PDF of Berlin program >

Berlin 2016 program


Local organizers

MedEd Global Solutions
27 rue Raffet
75016 Paris, France
Tel.: +33 14 401 5181
Cell: +33 67 191 9977
E-mail: hbaron@mededgs.com

Sunday 11th December 2016

7:15 – 8:15   Ken Fearon  Career Café – Meet the Mentors – Coordinated by Mitja Lainscak, Slovenia

7:15 – 8:15   Statistical SeminarChaired by Jennifer Le-Rademacher, USA

7:15 – 8:15   Breakfast Symposium

Role of mitochondrial dysfunction in skeletal muscle impairment: common and rare diseases – supported by Stealth Biotherapeutics
Chair: Stefan Anker, Germany

Welcome and introduction Stefan Anker, Germany
Kidney disease and skeletal muscle impairment: targeting mitochondrial energetics Baback Roshanravan, USA
Diagnosis and treatment of common and rare mitochondrial diseases Amel Karaa, USA
The role of skeletal muscle bioenergetics in aging and heart failure Stefan Anker, Germany
Discussion and closing remarks

Session E

8:30 – 10:00   Exercise, nutrition and metabolic problems in cachexia 
Chair: Alessandro Laviano, Italy and  Michael Toth, USA
Panelists: Josep Argiles, Spain, Tommy Cederholm, Sweden, James Carson, USA, William Evans, USA, Andrew Judge, USA and Annemie Schols, The Netherlands

Contraction and nutrition interaction in cachectic skeletal muscle: the anabolic response James Carson, USA
FoxO and FoxO regulation in the pathogenesis of muscle wasting Andrew Judge, USA
Nutrition and exercise interaction – update 2016 William Evans, USA
Exercise and anabolics Annemie Schols, The Netherlands
Panel discussion

10:00 – 11:00   Coffee break & science

10:10 – 10:50   Poster sessions

Poster session 9 Muscle wasting, sarcopenia, myopenia IV (posters 1-40 to 1-52)
Chairs: Serguei Fetissov, Jean Woo

Poster session 10 Muscle wasting, sarcopenia, myopenia V (posters 1-53 to 1-64)
Chairs: Didier Attaix, Carla Prado

Poster session 11 – Nutrition & appetite (posters 6-01 to 6-13)
Chairs: William Evans, Robert Mak

Session F

11:00 13:00   Special problems in muscle wasting
Chairs: Zudin Puthucheary, UK, Piotr Rozentryt, Poland and Joerg Schefold, Switzerland

Burns Teresa Zimmers, USA
Role of brain in controlling anorexia and cachexia Robert Mak, USA
Myopathy due to statin therapy Josep Argilés, Spain
Mitochondriopathies Michelangelo Mancuso, Italy
Muscle wasting in chronic liver disease Srinivasan Dasarathy, USA
Lipid changes at the interface between muscle and nervous system: the initial step of sarcopenia? Alessandro Laviano, Italy

13:00 – 14:30   Break

13:15 – 14:15    Lunch symposium

Role of ß-hydroxy-ß-methylbutyrate (HMB) in preserving muscle
Supported by Abbott Nutrition

Moderator: John Morley, USA
Importance of nutrition in maintaining muscle – John Morley, USA
Metabolic role of muscle and effects of HMB on muscle – Josef Argilés, Spain
Clinical evidence for HMB in older adults – Phil Atherton, UK
Closing remarks – John Morley, USA

Session G

14:30 – 15:30   Late breaking science/trials
Chairs: Andrew Coats, UK and John Morley, USA

Accelerated grip strength decline in older men with poor health and hormonal deficits – the prospective STRAMBO study (poster 1-13) – Pawel Szulc, France
The metabolic effects of a vitamin D and leucine enriched breakfast in elderly men: A double-blind, randomized intervention study (posters 6-04, 6-05) – Yves Boirie, France
MMPOWER: The effect of treatment with elamipretide in patients with genetically confirmed primary mitochondrial disease (PMD) (poster 1-61) – Amel Karaa, USA
Elamipretide improves skeletal muscle function in elderly subjects: Results from a randomized,double-blind, placebo-controlled, single IV-dose study (poster 1-62) – Baback Roshanravan, USA
Targeted medical nutrition in pre-cachectic and cachectic COPD patients (poster 2-15) – Annemie Schols, The Netherlands

Session H

15:30 – 17:30   Update on therapy of cachexia and muscle wasting
Chairs: Stefan Anker, Germany and Maurizio Muscaritoli, Italy

The pipeline in basic science – David Glass, USA
In early clinical development – Ronenn Roubenoff, USA
Anti-inflammatory therapies – Aminah Jatoi, USA
All kinds of anabolics – Jose Garcia, USA
All kinds of other approaches – Andrew Coats, UK
Comments from the regulators – Giuseppe Rosano, UK


PDF of the program of this 9th congress – Berlin, 10-11 December 2016 may be downloaded here:
9th Cachexia Conference program – Berlin 2016 >

To view the past program for the 8th Cachexia Conference held in Paris, December 2015:
8th Cachexia Conference program – Paris 2015 >